TipRanks
Go Ultimate55% OFF

Inhibikase Therapeutics (IKT) Balance Sheet

Inhibikase Therapeutics Balance Sheet

Inhibikase Therapeutics's total assets for Q2 2026 were $163.59M, a decrease of 5.62% from the previous quarter. IKT total liabilities were $10.26M for the fiscal quarter, a 79.62% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Mar 23Mar 22
$ 181.20M$ 98.60M$ 14.51M$ 24.94M$ 42.47M
$ 8.30M$ 3.73M$ 3.53M$ 3.90M$ 4.05M
$ 172.90M$ 94.87M$ 10.98M$ 21.04M$ 38.42M

Currency in USD

Inhibikase Therapeutics Debt to Assets

080M160M240M0 %5000 %10000 %15000 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets